Drones in the National Airspace System, and More from CRS
New reports from the Congressional Research Service that have not been made available to the public include the following.
Pilotless Drones: Background and Considerations for Congress Regarding Unmanned Aircraft Operations in the National Airspace System, September 10, 2012
Global Access to Clean Drinking Water and Sanitation: U.S. and International Programs, September 10, 2012
Automobile and Truck Fuel Economy (CAFE) and Greenhouse Gas Standards, September 11, 2012
Overview of the Federal Procurement Process and Resources, September 11, 2012
Presidential Review of Independent Regulatory Commission Rulemaking: Legal Issues, September 10, 2012
Terrorism Risk Insurance: Issue Analysis and Overview of Current Program, September 10, 2012
Arizona v. United States: A Limited Role for States in Immigration Enforcement, September 10, 2012
Authority of State and Local Police to Enforce Federal Immigration Law, updated September 10, 2012
Intelligence, Surveillance, and Reconnaissance (ISR) Acquisition: Issues for Congress, updated September 10, 2012
The latter report on ISR acquisition was co-authored by veteran CRS specialist Richard F. Grimmett. On Monday, Sen. Richard Lugar paid tribute on the Senate floor to Mr. Grimmett, who is retiring at the end of the month.
Confirmation that the construction of the security perimeter and associated security infrastructure at RAF Lakenheath are still ongoing once again raises questions about whether U.S. nuclear weapons have already been deployed to the base.
Alaskans are sensibly pulling back from the vogue for bans and returning to a western tradition that has worked for more than half a century – one that welcomes innovation but also oversees it closely.
The strength of our nation’s data policy isn’t just in the rules we write, but in how effectively we translate those rules into a system that prioritizes the public good. Join us in this movement to design and build more resilient national data policies.
The human cost is measured in deaths. The financial cost is measured in the $52 billion taxpayers pay annually end stage renal disease – double NASA’s budget.